This inventor holds 6 USPTO granted patents. Top assignees: Nippon Shinyaku Company, Ltd., Other. Active years: 1977-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Suita, JA (1977)
- Minami Kyoto, JA (1977)
- Kyoto, JP (1980)
- Suita, JP (1978 - 1986)
Company Filing History:
Years Active: 1977-1986
Title: Kenji Sempuku: Innovator in Pharmaceutical Chemistry
Introduction
Kenji Sempuku is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various medical conditions. With a total of 6 patents to his name, Sempuku's work has the potential to impact the treatment of pain, inflammation, and allergies.
Latest Patents
Sempuku's latest patents include innovative triazine derivatives designed to treat pain, fever, inflammation, and allergies. These compounds are characterized by their unique formula, which includes pharmaceutically acceptable salts where R¹ and R² can vary, and X and Y can be hydrogen or nicotinoyl. These compounds are recognized for their utility as anti-edema agents, anti-inflammatories, analgesics, anti-pyretics, anti-allergenics, and anti-thrombosis agents.
Career Highlights
Throughout his career, Kenji Sempuku has worked with reputable organizations, including Nippon Shinyaku Company, Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective medical treatments.
Collaborations
Sempuku has collaborated with notable colleagues such as Hiromu Murai and Katsuya Ohata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Kenji Sempuku's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments that can improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile